Company / Assets per Share
Kymera Therapeutics, Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$26.86
FY2025
5-year range
$11.70 / $26.86
FY2021-FY2025
Trend
+52.6%
vs FY2024
Sector context
#44 of 210
Health Care
What the data says
Kymera Therapeutics, Inc.'s assets per share of $26.86 is higher than 79% of companies in the Health Care sector (FY2025). Assets per Share has increased for 3 consecutive years, from $11.70 in FY2022 to $26.86 in FY2025.
Based on SEC 10-K filings.
26.86 in FY2025 with a 5-year CAGR of -36.1%. Top quartile in the Health Care sector.
Improved from $12.00 to $26.86 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +31.9%
- 5-Year CAGR
- -36.1%
- 10-Year CAGR
- -
Sector benchmark
-91.0% below sector average
Key checks
Key Insights
- Kymera Therapeutics, Inc.'s assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 52.6% year-over-year.
- Ranks #44 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.86 | +52.6% |
| FY2024 | $17.60 | +46.7% |
| FY2023 | $12.00 | +2.5% |
| FY2022 | $11.70 | -14.1% |
| FY2021 | $13.62 | -94.6% |
| FY2020 | $252.49 | +267.5% |
| FY2019 | $68.71 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026